Identiv launched uTrust Sense SyringeCheck, a smart injectable dose monitoring device designed to help patients take medication properly.
It is the only smart injectable technology available today, and will help clinical trials achieve meaningful results, support insurance companies in providing valuable prescription programs, and make the lives of those receiving and using medication easier, according to the company.
The near field communication (NFC)-enabled syringe dose monitoring device features a front-end capacitive sensor that measures fill levels, working in combination with a companion app and alarm function to guide patients through correct medication intake and greatly simplify what can often be complex prescription courses, Identiv said.
Five Benefits of uTrust Sense SyringeCheck
- Enhanced clinical trial process: Conduct trials in a natural environment (i.e., at home) as opposed to a clinic;
- Enhanced clinical trial results: Easily identify non-compliant participants, exclude them from results, and save money with more efficient phase IV studies;
- Help for insurance companies: Ensure expensive medication is paid for by insurance firms with easy compliance confirmation;
- Simplified prescription plans: Combine reminders and alarms via the app to carefully manage prescription intakes;
- Improved patient outcomes: Assist at-risk patients who need to take medicine but may forget to do so.
Globally, in monetary terms, medication errors cost $42 billion, equating to around 1% of total expenditure on healthcare, Identiv noted.
